NCT01134341 2019-12-18
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Acrotech Biopharma Inc.
Phase 1 Completed
Clinical Trials
1 trialsCompleted × Lymphoma, Primary Cutaneous Anaplastic Large Cell × 10-propargyl-10-deazaaminopterin × Clear all